MMV390048 and Its Antimalarial Activity Against Plasmodium Falciparum in Healthy Adult Subjects, Part B

NCT02783833 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Malaria

Interventions

DRUG: MMV390048 40mg
DRUG: MMV390048 dose to be determined mg

Sponsor

Medicines for Malaria Venture

Collaborators

[object Object]
[object Object]
[object Object]